Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment

  1. Cerezo-Manchado, J.J.
  2. Roldan, V.
  3. Rosafalco, M.
  4. Anton, A.I.
  5. Arroyo, A.B.
  6. Garcia-Barbera, N.
  7. Martínez, A.B.
  8. Padilla, J.
  9. Corral, J.
  10. Vicente, V.
  11. Gonzalez-Conejero, R.
Aldizkaria:
Pharmacogenomics

ISSN: 1744-8042 1462-2416

Argitalpen urtea: 2014

Alea: 15

Zenbakia: 7

Orrialdeak: 987-996

Mota: Artikulua

DOI: 10.2217/PGS.13.232 GOOGLE SCHOLAR